Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02427204 · ClinicalTrials.gov registry record
Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality
A clinical trial of Hepatitis C Infection, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT02427204 is a study of Hepatitis C Infection that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 150 participants, below the 1,333-participant average among 3 other Hepatitis C Infection trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02427204, a study of Hepatitis C Infection, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The main questions being addressed are (1) how patient reported outcomes change during treatment for HCV, (2) how treatment impacts liver function and liver status, and (3) how much treatment costs from the payer's perspective and the patient's perspective. The hypothesis being tested is that treatment has a negative effect on the quality of life during treatment. The negative effect is expected to be temporary. Successful treatment, which is equated with a virological cure of the infection, is expected to result in an improvement in quality of life compared to baseline and to improvement in markers of liver function and liver status. Costs of treatment are expected to be $80,000-$200,000 per virological cure.
Conditions Studied
Study Locations (1)
New York
- Icahn School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2015-06 |
| Est. Completion | 2018-01-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02427204
The ClinicalTrials.gov registry entry for NCT02427204 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,333-participant average among 3 other Hepatitis C Infection trials with a reported enrollment target (89% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hepatitis C Infection appearing as the primary indexed condition, and to 0 interventions.
NCT02427204 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02427204 about?
NCT02427204 is a clinical study titled "Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality". The main questions being addressed are (1) how patient reported outcomes change during treatment for HCV, (2) how treatment impacts liver function and liver status, and (3) how much treatment costs from the payer's perspective and the patient's perspective. The hypothesis being tested is that treatm...
What is the current status of trial NCT02427204?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2015-06. Estimated completion is 2018-01-18.
What conditions does trial NCT02427204 study?
This clinical trial studies the following conditions: Hepatitis C Infection.
Who is sponsoring clinical trial NCT02427204?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02427204 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.